Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
1.4500
+0.0600
+(4.32%)
As of 9:59:02 AM GMT+1. Market Open.
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Cash Flows from Used in Operating Activities Direct
-44,741
-48,458
-63,269
-65,782
--
Operating Cash Flow
--
-48,458
-63,269
-65,782
-100,749
Investing Cash Flow
53
-97
-194
-232
-1,647
Financing Cash Flow
41,534
40,252
74,502
-9,870
108,534
End Cash Position
50,023
62,960
71,318
60,447
136,881
Capital Expenditure
-185
-331
-314
-232
-1,647
Issuance of Capital Stock
65,406
65,406
88,635
209
106,268
Issuance of Debt
--
--
--
51,919
--
Repayment of Debt
--
-13,522
-2,656
-58,246
-2,931
Free Cash Flow
-44,926
-48,789
-63,583
-66,014
-102,396
6/30/2021 - 1/26/2006
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
1VT.F Viking Therapeutics, Inc.
26.81
-3.91%
NGENF NervGen Pharma Corp.
1.9150
-0.26%
CNTB Connect Biopharma Holdings Limited
0.9099
+1.10%
PHRRF PharmaTher Holdings Ltd.
0.1420
+4.80%
KYTX Kyverna Therapeutics, Inc.
2.8400
+1.43%
LYRA Lyra Therapeutics, Inc.
0.2140
+5.52%
ATHE Alterity Therapeutics Limited
3.7800
-2.33%
ABEO Abeona Therapeutics Inc.
5.24
+1.95%
TSHA Taysha Gene Therapies, Inc.
1.6000
+0.63%
MURA Mural Oncology plc
3.6800
+0.55%